KLIFO has announced that Alejandra Mørk has taken the decision to step down as CEO and the company has appointed Rasmus Nelund as the new CEO.
Alejandra Mørk will step into a new role as senior client advisor and Board member. Two years ago, a new phase in KLIFO’s development journey began when Alejandra Mørk sold the majority stake in KLIFO to Gilde Healthcare to facilitate the next steps in KLIFO’s expansion.
“Today, KLIFO is a strong, well-established North-European end to end drug development consultancy, and we still have so much potential. Now the time is right to take a significant step forward and pass the CEO baton to Rasmus Nelund. I look forward to stepping into new roles at KLIFO as senior client advisor and Board member while also freeing up time for my other professional commitments,” says Alejandra Mørk.
Rasmus Nelund joins KLIFO with more than 20 years of experience as a leader in the international life sciences industry. For the last 10 years, as Corporate Vice President at NNIT A/S, Rasmus led the company’s strong international growth by supporting life sciences companies in their business transformation fuelled by technological change. He did this in senior leadership positions focusing on customer success, strategic execution, M&A and organisational development. Before joining NNIT, he co-founded the Clinical IT consulting company Herax A/S and served as CEO at Pipeline Biotech A/S, a CRO, specialised in preclinical research services.
“KLIFO has a strong reputation in the life science industry, and I’m very impressed with KLIFO’s culture, way of working and impressive development. I look forward to building further on this great foundation together with KLIFO’s leadership team and its many committed employees”, says Rasmus Nelund.
“KLIFO embodies Alejandra’s ideas and leadership. Alejandra has inspired KLIFO’s fundamental business idea and culture, encompassing deep competencies in end to end drug development, collaboration, passion for clients and trust-based leadership. We respect her decision to step down and very much look forward to collaborating with Alejandra in her new roles. We cannot thank Alejandra enough; she has built a great company and legacy,” says the Chairman of KLIFO’s Board of Directors, Niels Peder Nielsen. ”The Board and Gilde Healthcare are very excited to welcome Rasmus Nelund as CEO. Rasmus represents both continuity and renewal with his strong competencies to lead the development of KLIFO going forward. Rasmus’ extensive life sciences consulting background, his international growth experience and his culture-based leadership style will be a strong match and enabler to fulfilling the ambitions of KLIFO. We look forward to Rasmus working closely with KLIFO’s leaders and employees on KLIFO’s exciting onward journey”.
Photo of Rasmus Nelund: KLIFO